Article
Laureate to Produce Antibody for Lpath
Author(s):
Lpath, Inc. (San Diego, CA, www.lpath.com) and Laureate Pharma, Inc. (Princeton, NJ, www.laureatepharma.com) have entered into an agreement for Laureate to manufacture Lpath's recombinant humanized monoclonal antibody, "Sphingomab," against bioactive lipids.
Lpath, Inc. (San Diego, CA, www.lpath.com) and Laureate Pharma, Inc. (Princeton, NJ, www.laureatepharma.com) have entered into an agreement for Laureate to manufacture Lpath’s recombinant humanized monoclonal antibody, “Sphingomab,” against bioactive lipids. Laureate will provide cell line development, optimization, and upstream and downstream process development, followed by cGMP manufacture for the product for use in clinical trials.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
